close

A Community-Based Pathway For Hepatitis B Screening

Hepatitis B remains a significant public health concern in Australia, yet many people living with the virus do not know they have it. Chronic infection can cause liver inflammation, cirrhosis, and liver cancer, while timely diagnosis and monitoring can substantially reduce preventable illness. A community-based screening program for hepatitis B in culturally and linguistically diverse populations can bring testing closer to the places where trust, language, and everyday support already exist.

Australia’s diverse population includes people born in South-East Asia, the Pacific, sub-Saharan Africa, the Middle East, and other regions where hepatitis B is more common. In Brisbane, Logan, Ipswich, and surrounding Queensland communities, a person’s first contact with healthcare may be through a community centre, faith organisation, migration service, pharmacy, or bilingual health worker rather than a regular general practitioner.

An effective program must therefore combine clinical accuracy with cultural safety. It should offer confidential screening, clear explanations, appropriate referrals, and practical support through Medicare, interpreters, transport, and follow-up care. The aim is to identify infection early while making participation comfortable for individuals, families, and communities.

Why Local Screening Matters

Hepatitis B can be transmitted from mother to child during childbirth, through household exposure in early life, or through blood and sexual contact. Many people with chronic infection have no symptoms for years. A normal appearance or lack of pain should never be treated as evidence that testing is unnecessary.

Australia has strong national guidance, childhood immunisation, and antenatal screening, but gaps remain. Adults who arrived before routine vaccination became widely available may not have been tested, and some people face language barriers, fear of stigma, limited health literacy, or uncertainty about the cost of care. A community hepatitis service can help close these gaps without placing responsibility solely on individuals.

Screening should include appropriate blood tests for hepatitis B surface antigen, surface antibody, and core antibody, followed by clinical assessment when results indicate current or past infection. The process should distinguish active infection, immunity, and susceptibility so that people receive vaccination, monitoring, treatment, or reassurance as appropriate.

Designing Trustworthy Pathways

Trust begins before the blood test. Program staff should work with multicultural health organisations, community leaders, settlement services, general practices, maternity services, and local councils to understand customs and concerns. Consultation should include people from the communities the program intends to reach, with paid participation where possible.

Information needs to be available in commonly used languages, using plain English alongside translated materials. NAATI-certified interpreters should be offered rather than relying on children or relatives to interpret sensitive medical information. Consent must be private and voluntary, with a clear explanation of confidentiality, results, treatment options, and the right to withdraw.

Cultural safety also means avoiding assumptions. Some participants may prefer a female clinician, a same-language worker, or a separate appointment from family members. Others may value group education at a community event before choosing individual testing. Flexibility allows the program to respect cultural practices without compromising clinical standards.

Finding People Where They Are

Screening can be offered through pop-up clinics at community centres, shopping precincts, workplaces, universities, places of worship, and multicultural festivals. In Brisbane, partnerships with local neighbourhood houses and migrant resource centres may reach residents who rarely attend mainstream health campaigns. Outreach in Logan and Ipswich can also connect with families who experience transport or appointment barriers.

Community health workers can explain the purpose of testing, check eligibility, arrange appointments, and support result collection. Text messages, translated phone calls, and reminder cards may be useful, provided participants consent to the contact method. Programs should avoid displaying hepatitis B branding in ways that could unintentionally disclose a person’s health concerns.

A screening event should offer a complete pathway rather than a one-off test. Participants need a documented result, a clinician review where necessary, vaccination access for those who are susceptible, and a referral route for specialist assessment. After-hours sessions can assist shift workers, while mobile services may help people in outer metropolitan areas and regional Queensland.

Testing, Treatment And Follow-Up

Positive screening results require sensitive communication and prompt clinical follow-up. A trained clinician should explain that hepatitis B is manageable, that infection does not define a person’s identity, and that household and sexual contacts may need testing or vaccination. People should receive written information in their preferred language and a clear next appointment.

Not everyone with chronic hepatitis B needs immediate antiviral treatment, but everyone with confirmed chronic infection needs appropriate assessment and ongoing monitoring. This may include liver function tests, viral load assessment, imaging, and specialist review according to clinical guidance. Care should be coordinated between GPs, hepatology services, pathology providers, and community health workers.

Pregnancy creates an important opportunity for prevention. Antenatal services should confirm hepatitis B results, arrange specialist advice when indicated, and support timely newborn vaccination and immunoglobulin according to Australian recommendations. Families need explanations that are respectful, reassuring, and free from blame.

Practical Program Components And Measures

A strong service can begin with a small pilot and expand according to demand. Brisbane Diamantina Health Partners offers a useful model for connecting research institutes, universities, and health services so that community findings can inform clinical practice and service design through health research partnerships.

Core delivery features

  • Bilingual community health workers and accredited interpreters
  • Confidential screening linked to vaccination and clinical referral
  • Flexible appointments in trusted local venues
  • Written and digital information in priority community languages

Evaluation should measure more than the number of blood tests completed. The program should examine whether participants received results, reached follow-up care, commenced treatment when recommended, and experienced respectful communication. Data should be reported by language, age, sex, location, and other relevant factors without compromising privacy.

Useful evaluation measures

  • Screening uptake and proportion of positive results
  • Time from screening to clinical assessment
  • Vaccination completion among susceptible participants
  • Participant-reported trust, understanding, and cultural safety

Research can strengthen the program over time. For example, laboratory and translational teams may investigate new approaches to biomarkers, disease monitoring, and patient communication. Networks such as the extracellular vesicle community demonstrate how specialised research communities can contribute to better understanding of biological signals, although established hepatitis B testing and clinical guidelines must remain the foundation of care.

Building A Sustainable Partnership

Long-term success depends on shared ownership. Health services can provide clinical governance and referral capacity, universities can support evaluation, and community organisations can guide communication and outreach. Funding should cover interpreters, transport assistance, workforce training, data management, and participant engagement rather than focusing only on pathology costs.

The program should align with Australia’s primary healthcare system and local public health priorities. Clear referral agreements can reduce loss to follow-up, while shared protocols help staff respond consistently to abnormal results. Training should include hepatitis B knowledge, stigma reduction, trauma-informed communication, privacy, and culturally safe practice.

Community representatives should have a continuing role in governance, not just a role during launch. Regular feedback sessions can identify practical problems such as inconvenient clinic hours, unclear letters, or concerns about family disclosure. Adapting the service in response to this feedback helps maintain confidence and improves health outcomes.

A community-based screening program can make hepatitis B testing visible, routine, and accessible without making individuals feel exposed. Health services, researchers, community organisations, and local leaders across Queensland can work together to establish trusted pathways, strengthen prevention, and ensure that every positive result leads to informed care. Build the partnership, fund the outreach, and make culturally safe hepatitis B screening part of everyday community health.

Our Partners